Sano connects people with research in personalised medicine
We provide access to free genome sequencing and analysis for research participants. You own your data and have full control over how it used.
Experienced in genomics research with a focus on large-scale genome sequencing projects and rare disorders. Previously at the Wellcome Trust Sanger Institute and the University of Cambridge.
Computer scientist previously working on deep learning and genetics at the Wellcome Trust Sanger Institute and the University of Cambridge.
Experienced in single-cell genomics research, studying childhood cancer. Previously at the Wellcome Trust Sanger Institute, the University of Cambridge and JPMorgan.
Head of Marketing
Front End Developer
Head of Business Development
Our Cambridge Office
Our main offices and core team are in the The Bradfield Center.
184 Cambridge Science Park Milton Road, Milton, Cambridge CB4 0GA.
Maybe a question you have about our platform is answered here.
If not, please don't hesitate to get in touch by email or use the chat service to contact us.
We make money by providing tools for researchers to analyse anonymous and aggregated data that has been provided with the consent of our users when they choose to participate in research.
We also help researchers to recruit for their studies and clinical trials based on data that our users provide, if they have opted to share it for this purpose. We believe medical research should be transparent, interactive, and beneficial to everyone involved. This is why we always ask for permission, provide a complete summary of the research findings, and offer financial compensation whenever possible.
We also believe that users should share in the value generated from their data, but there are still a lot of challenges to make this model work. We are working hard on the legal and regulatory front to enable revenue sharing with participants, and in finding research partners willing to trial new models of incentivising participation.
Your data will never be sold without your permission. We built Sano Genetics because we believe we should not have to choose between data privacy and access to cutting edge research. We don't believe in business models shrouded in secrecy, where users find out their data has been sold on through a national news scandal.
Once you’ve created your account, you will have access to all of the studies we are currently running. We will also send you updates the moment a new research project becomes available. From the account menu you can also input your medical history and other information about yourself. Once we have enough people with the same genetic condition or trait we will inform our research partners of the research opportunity.
We are supporting studies on the genetics of human traits including addiction, sleep habits, memory, gluten intolerance, taste preferences and more. The purpose of these studies is to improve our understanding of how our DNA influences fundamental human traits.
We are currently running a research study with researchers from the University of Cambridge on autism and mathematical abilities with an aim of understanding the genetics of neurodiversity.
We have also partnered with patient groups to launch studies on Muscular Dystrophy and Phelan McDermid Syndrome with the aim of accelerating research on these rare and understudied disorders.
We use industry standard encryption mechanisms both in transit and at rest when dealing with your data. This means that your data is safe and secure, whether or not you choose to share it.
Any information sent between your computer and our servers is encrypted using SSL - you can always check that the padlock icon in your internet browser is present to ensure you are interacting with our site, and not a site trying to impersonate us to steal your data.
We are values driven. We believe any company, but particularly companies specialising in DNA sequencing, should have ethical practices, transparent communication and a business model which is socially responsible.
We also use more advanced DNA sequencing technology (whole exome sequencing and whole genome sequencing) than most other companies, which provides much more data, enhancing insight derived from studies.